Compare · RMD vs VJET
RMD vs VJET
Side-by-side comparison of ResMed Inc. (RMD) and Flyte Aviation Inc. (VJET): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both RMD and VJET operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- RMD is the larger of the two at $34.12B, about 23967.5x VJET ($1.4M).
- Over the past year, RMD is down 0.9% and VJET is down 97.6% - RMD leads by 96.7 points.
- RMD has been more active in the news (13 items in the past 4 weeks vs 7 for VJET).
- RMD has more recent analyst coverage (25 ratings vs 0 for VJET).
- Company
- ResMed Inc.
- Flyte Aviation Inc.
- Price
- -
- -
- Market cap
- $34.12B
- $1.4M
- 1M return
- -1.00%
- -46.97%
- 1Y return
- -0.87%
- -97.56%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NYSE
- AMEX
- IPO
- News (4w)
- 13
- 7
- Recent ratings
- 25
- 0
ResMed Inc.
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders comprising sleep apnea, chronic obstructive pulmonary disease, neuromuscular disease, and other chronic diseases. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, portable oxygen concentrators, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides U-Sleep, which enables automated patient coaching through a text, email, or interactive voice phone call; AirView that enables remote monitoring, over-the-air trouble shooting, and changing of device settings; and myAir, a patient engagement application that offers sleep data and a daily score based on their previous night's data, as well as connectivity module and propeller solutions. In addition, it provides business management software and services to out-of-hospital providers, home medical equipment, pharmacy, home infusion, orthotics, and prosthetics; and HEALTHCAREfirst and MatrixCare solutions. The company markets its products to sleep clinics, home healthcare dealers, patients, hospitals, physicians, and third-party payers through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
Flyte Aviation Inc.
Flyte Aviation, Inc. (NYSE American: VJET) is a technology-enabled private aviation company focused on modernizing how consumers access private air travel. Through its Flyte brand, the Company operates a growing fleet of Cirrus Vision Jets and is building a scalable aviation platform designed to connect customers, aircraft, operators, and aviation services. Flyte's simple value proposition: privacy, comfort, reliability, and convenience - at a highly competitive price. Through its direct-to-consumer booking platform, standardized pricing on select routes, strategic partnerships, and FAA-certified Part 135 operating subsidiary, Ponderosa Air, LLC, Flyte is focused on delivering what it believes is a faster, safer and more convenient private aviation experience while expanding its technology, customer network, and geographic footprint.
Latest RMD
- Director Jan De Witte sold $101,673 worth of ResMed Common Stock (429 units at $237.00) as part of a pre-agreed trading plan, decreasing direct ownership by 10% to 3,772 units (SEC Form 4)
- Chairman and CEO Farrell Michael J. covered exercise/tax liability with 8,111 units of ResMed Common Stock, decreasing direct ownership by 2% to 471,774 units (SEC Form 4) (tax withholding)
- Chief Financial Officer Bloomer Aaron covered exercise/tax liability with 1,095 units of ResMed Common Stock, decreasing direct ownership by 12% to 7,977 units (SEC Form 4) to satisfy withholding tax
- Director Farrell Peter C covered exercise/tax liability with 169 units of ResMed Common Stock, decreasing direct ownership by 0.33% to 51,634 units (SEC Form 4) (withholding obligation)
- Director De Witte Jan covered exercise/tax liability with 60 units of ResMed Common Stock, decreasing direct ownership by 1% to 4,201 units (SEC Form 4) (for tax liability)
- Director Gill Harjit covered exercise/tax liability with 36 units of ResMed Common Stock, decreasing direct ownership by 0.33% to 10,904 units (SEC Form 4) (withholding tax)
- Global General Counsel Rider Michael J covered exercise/tax liability with 1,944 units of ResMed Common Stock, decreasing direct ownership by 16% to 10,417 units (SEC Form 4) (withholding obligation)
- Chairman and CEO Farrell Michael J. exercised 4,993 units of ResMed Common Stock at a strike of $146.34 and sold $1,175,089 worth of ResMed Common Stock (4,993 units at $235.35) as part of a pre-agreed trading plan (SEC Form 4)
- ResMed downgraded by Canaccord Genuity
- SEC Form 10-Q filed by ResMed Inc.
Latest VJET
- Flyte Aviation Reports Record Third Quarter 2026 Aviation Revenue Increasing 145% Sequentially
- Catheter Precision Partners With Two New German Heart Centers
- Flyte Aviation Launches Flyte Club to Disrupt Jet Cards and Fractional Ownership Programs with Transparent Per-Trip Pricing and Savings Up to 30%
- Flyte Aviation Executes Letter of Intent to Sell Cardiology Assets
- Catheter Precision Announces New FDA 510(k) Clearance for its VIVO System, Enabling Use in a Broader Patient Population
- Flyte Aviation Expands International Operations to Canada
- Flyte Aviation, One of the Nation’s Largest Vision Jet Operators, Congratulates Cirrus Aircraft on Ten Years of Innovation
- Catheter Precision Announces Publication of Comparative Study Showing LockeT Outperforms Abbott’s Perclose Internal Vascular Closure Device
- Flyte Aviation Establishes New B2B Distribution Channel, Launches Partner Portal
- Flyte Aviation Partners with The Philadelphia 76ers